Healthcare & Life Sciences
Xinnate
Swedenwww.xinnate.com
Xinnate is a Healthcare & Life Sciences startup based in Sweden, most recent round Series A, 1 tracked investor.
activeseries-a
series-a
Stage
2018
Founded
1
Investors
About Xinnate
Xinnate is a company founded in 2018 headquartered in Sweden. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Xinnate is a clinical-stage pharmaceutical company developing next-generation therapies built on proprietary peptide technology designed to restore balance in dysfunctional wound healing, particularly for Epidermolysis Bullosa and other inflammatory skin disorders.
Explore Xinnate's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.